» Articles » PMID: 16793893

Phototransduction in a Transgenic Mouse Model of Nougaret Night Blindness

Overview
Journal J Neurosci
Specialty Neurology
Date 2006 Jun 24
PMID 16793893
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The Nougaret form of dominant stationary night blindness is linked to a G38D mutation in the rod transducin-alpha subunit (Talpha). In this study, we have examined the mechanism of Nougaret night blindness using transgenic mice expressing TalphaG38D. The biochemical, electrophysiological, and vision-dependent behavioral analyses of the mouse model revealed a unique phenotype of reduced rod sensitivity, impaired activation, and slowed recovery of the phototransduction cascade. Two key deficiencies in TalphaG38D function, its poor ability to activate PDE6 (cGMP phosphodiesterase) and decreased GTPase activity, are found to be the major mechanisms altering visual signaling in transgenic mice. Despite these defects, rod-mediated sensitivity in heterozygous mice is not decreased to the extent seen in heterozygous Nougaret patients.

Citing Articles

Toward a clinical optoretinogram: a review of noninvasive, optical tests of retinal neural function.

Jonnal R Ann Transl Med. 2021; 9(15):1270.

PMID: 34532407 PMC: 8421939. DOI: 10.21037/atm-20-6440.


Coexistence of GNAT1 and ABCA4 variants associated with Nougaret-type congenital stationary night blindness and childhood-onset cone-rod dystrophy.

Hayashi T, Hosono K, Kurata K, Katagiri S, Mizobuchi K, Ueno S Doc Ophthalmol. 2019; 140(2):147-157.

PMID: 31583501 DOI: 10.1007/s10633-019-09727-1.


A Novel Heterozygous Missense Mutation in Leads to Autosomal Dominant Riggs Type of Congenital Stationary Night Blindness.

Zeitz C, Mejecase C, Stevenard M, Michiels C, Audo I, Marmor M Biomed Res Int. 2018; 2018:7694801.

PMID: 29850563 PMC: 5937575. DOI: 10.1155/2018/7694801.


Identification of a Novel Homozygous Nonsense Mutation Confirms the Implication of GNAT1 in Rod-Cone Dystrophy.

Mejecase C, Laurent-Coriat C, Mayer C, Poch O, Mohand-Said S, Prevot C PLoS One. 2016; 11(12):e0168271.

PMID: 27977773 PMC: 5158031. DOI: 10.1371/journal.pone.0168271.


Dominant-negative Gα subunits are a mechanism of dysregulated heterotrimeric G protein signaling in human disease.

Marivin A, Leyme A, Parag-Sharma K, DiGiacomo V, Cheung A, Nguyen L Sci Signal. 2016; 9(423):ra37.

PMID: 27072656 PMC: 4870087. DOI: 10.1126/scisignal.aad2429.


References
1.
Makino E, Handy J, Li T, Arshavsky V . The GTPase activating factor for transducin in rod photoreceptors is the complex between RGS9 and type 5 G protein beta subunit. Proc Natl Acad Sci U S A. 1999; 96(5):1947-52. PMC: 26717. DOI: 10.1073/pnas.96.5.1947. View

2.
Farfel Z, Bourne H, Iiri T . The expanding spectrum of G protein diseases. N Engl J Med. 1999; 340(13):1012-20. DOI: 10.1056/NEJM199904013401306. View

3.
Chen C, Burns M, He W, Wensel T, Baylor D, Simon M . Slowed recovery of rod photoresponse in mice lacking the GTPase accelerating protein RGS9-1. Nature. 2000; 403(6769):557-60. DOI: 10.1038/35000601. View

4.
Muradov K, Artemyev N . Loss of the effector function in a transducin-alpha mutant associated with Nougaret night blindness. J Biol Chem. 2000; 275(10):6969-74. DOI: 10.1074/jbc.275.10.6969. View

5.
Danciger M, Matthes M, Yasamura D, Akhmedov N, Rickabaugh T, Gentleman S . A QTL on distal chromosome 3 that influences the severity of light-induced damage to mouse photoreceptors. Mamm Genome. 2000; 11(6):422-7. DOI: 10.1007/s003350010081. View